Lead sponsor
Astellas Pharma Inc
2 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
2
Trials led
0
Ongoing
570
Total enrollment
84
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 1
1
Phase 2
1
Trials by status
Completed
1
Terminated
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
A Randomized Study to Evaluate FK962 in Subjects With Mild to Moderate Alzheimer's DiseaseAlzheimer's diseasePh 2Terminated510
A Study of the Safety and Tolerability of ASP0777 in Subjects With Alzheimer's Disease (AD) Taking a Stable Dose of DonepezilAlzheimer's diseasePh 1Completed60